This page displays the list of publications related to Tucuxi, in reverse chronological order.

Alrahahleh D., Thoma Y., Van Daele R., Nguyen T., Halena S., Luig M., Stocker S., Kim H. Y. and Alffenaar J.-W. (2024), “Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring”, In Neonates Clinical Pharmacokinetics, To the paper

Philippe M., Guitton J., Goutelle S., Thoma Y., Favier B., Chtiba N., Michallet M. and Belhabri, A. (2024), “Pharmacokinetic Consideration of Venetoclax in Acute Myeloid Leukemia Patients: A Potential Candidate for TDM? A Short Communication”, In Therapeutic Drug Monitoring, Vol. 46(1), To the paper

Goutelle S., Wallet F., Thoma Y., Peclard J.-R., Bourguignon L., Cohen S., Kipnis E., Roberts J., Allaouchiche B. and Friggeri A. (2023), “AUC-based monitoring and model-informed precision dosing of vancomycin in critically ill patients: why and how?”, In Anaesthesia Critical Care & Pain Medicine, Vol. 42(6), To the paper

Goutelle S., Thoma Y., Buffet R., Philippe M., Buclin T., Guidi M. and Csajka C. (2022), “Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children”, In Pharmaceutics. Vol. 14(10) To the paper

Suttels V., André P., Thoma Y., Veuve F., Decosterd L., Guery B. and Buclin T. (2022), “Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing”, In JAC-Antimicrobial Resistance. Vol. 4(2) To the paper

Heitzmann J., Thoma Y., Bricca R., Gagnieu M.-C., Leclerc V., Roux S., Conrad A., Ferry T. and Goutelle S. (2022), “Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin”, Pharmaceutics. Vol. 14(1) To the paper

Drennan P.G., Thoma Y., Barry L., Matthey J., Sivam S. and van Hal S.J. (2021), “Bayesian Forecasting for Intravenous Tobramycin Dosing in Adults With Cystic Fibrosis Using One Versus Two Serum Concentrations in a Dosing Interval”, Therapeutic Drug Monitoring. Vol. 43(4) To the paper

Narayan S.W., Thoma Y., Drennan P.G., Yejin Kim H., Alffenaar J.-W., Van Hal S. and Patanwala A.E. (2021), “Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill”, Critical Care Medicine. Vol. 49(10), pp. 952-960. To the paper

Buclin T., Thoma Y., Widmer N., André P., Guidi M., Csajka C. and Decosterd L.A. (2020), “The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib”, Frontiers in Pharmacology. Vol. 11, pp. 177. To the paper

Dubovitskaya A., Buclin T., Schumacher M., Aberer K. and Thoma Y. (2017), “TUCUXI: An Intelligent System for Personalized Medicine from Individualization of Treatments to Research Databases and Back”, In Proceedings of the 8th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics. New York, NY, USA , pp. 223-232. ACM. To the paper

Fuchs A., Csajka C., Thoma Y., Buclin T., Widmer N. (2012), “Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools”, in Clinical Pharmacokinetics. Vol. 52(1), pp. 9-22. To the paper